Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Oncology is a Major Focus for Many AI Drug Discovery Companies, Reports IDTechEx
The application of artificial intelligence (AI) in the drug discovery process is promising to drastically […]
Babylon Secures New $200m Sustainability-Linked Investment to Fuel Rapid Growth Plan
Babylon Holdings Limited (“Babylon“), one of the world’s fastest-growing digital healthcare companies, today announced that […]
Legend Capital Leads ForQaly Medical's Series B Financing
ForQaly Medical (hereinafter referred to as “ForQaly”), located in Shanghai Zhangjiang International Medical Zone, is […]
Inhalon Doses First Patient in Phase 1 Study of Inhaled IN-006 to Treat COVID-19
Inhalon Biopharma, Inc., a clinical-stage immunotherapy company developing an inhaled “muco-trapping” antibody platform for treating […]
Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Amgen (NASDAQ: AMGN) and Neumora Therapeutics, Inc. (Neumora), a clinical-stage biopharmaceutical company pioneering precision medicines for […]
DarioHealth Announces Agreement with Global Employer for Metabolic and Musculoskeletal Health Solutions
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an […]
Boston Scientific Eluvia ™ Drug-Eluting Vascular Stent System Exhibits Superiority Compared to Bare Metal Stents
Today, Boston Scientific Corporation (NYSE: BSX) announced positive data for the Eluvia ™ Drug-Eluting Vascular Stent […]
SAGA Diagnostics Appoints Peter Collins as Chief Executive Officer
SAGA Diagnostics AB (“SAGA”), a leading cancer liquid biopsy and genomic testing company, has announced the […]
WHO Recommends Groundbreaking Malaria Vaccine for Children at Risk
The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine […]
Moderna Announces European Medicines Agency Authorizes Third Dose of COVID-19 Vaccine for Immunocompromised Individuals Aged 12 Years and Older
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more